Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Nov 10;47(12):6268–6277. doi: 10.1177/0300060519870723

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2019

Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 1. — BADGE ameliorates glucocorticoid induced bone mass loss. (a) Representative two-dimensional reconstruction of the femur. (b) Micro-computed tomography revealed that, compared with the normal group, dexamethasone treatment reduced Tb.Th, BV/TV, BMD, and Tb.N. Compared with the model group, BADGE treatment significantly increased trabecular BV/TV and BMD (n = 10). ^#P < 0.05 vs. model group and *P < 0.05 vs. normal group. BADGE, bisphenol A diglycidyl ether; Tb.Th, trabecular thickness; BV/TV, bone volume/total volume; BMD, bone mineral density; Tb.N, trabecular number.